Request Deal Involvement
Quince Therapeutics completed the acquisition of EryDel for $510m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Perella Weinberg Partners
legal advisors
Goodwin Procter
legal advisors
Clifford Chance
pr advisors
Barabino & Partners
financial advisors
MTS Health Partners
legal advisors
Cooley
pr advisors
Gagnier Communications
legal advisors
Chiomenti
accounting advisors
BDO
or
Principals
target
ERYDEL
bidder
QUINCE THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite